Want to see MNTN full AI Analyst Report?
MNTN Stock Chart & Stats
$8.58
$0.74(8.62%)
At close: 4:00 PM EDT
$8.58
$0.74(8.62%)
Day’s Range― - ―
52-Week Range$7.67 - $32.00
Previous Close$9.32
Volume1.10M
Average Volume (3M)1.37M
Market Cap
$688.97M
Enterprise Value$409.28M
Total Cash (Recent Filing)$213.90M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)30.1
Beta1.10
Next Earnings
Aug 04, 2026EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.32
Shares Outstanding61,013,454
10 Day Avg. Volume864,881
30 Day Avg. Volume1,369,984
Financial Highlights & Ratios
PEG Ratio1.72
Price to Book (P/B)2.88
Price to Sales (P/S)3.04
P/FCF Ratio20.06
Enterprise Value/Market Cap0.59
Enterprise Value/Revenue1.37
Enterprise Value/Gross Profit1.72
Enterprise Value/Ebitda11.74
Forecast
1Y Price Target
$20.14Price Target Upside134.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)0.93
Revenue Forecast (FY)$351.90M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet And Rebuilt EquityZero reported debt and a restored positive equity base (~$319M TTM) materially reduce financial risk and increase strategic optionality. This durable capital-structure improvement supports investment in sales, R&D, or M&A and provides a buffer against cyclical pressures while lowering refinancing and liquidity risk.
High Gross Margins And Sustained ProfitabilitySustained gross margins near 80% and a clear operating-profit inflection (EBIT ~15.7%) indicate structural pricing power and scalable product economics. Durable margin advantages improve cash generation potential, support reinvestment, and make the business less sensitive to modest revenue fluctuations over the medium term.
Regulatory Approvals And Accelerated Clinical ProgressCE Mark approvals and faster-than-expected BOX NOAF enrollment strengthen the company's pathway to international launches and evidence-driven adoption. Regulatory clearance plus accelerated trial progress create durable product expansion channels, supporting sustainable revenue growth and competitive positioning across markets.
Bears Say
Revenue Growth Has Meaningfully Cooled From Prior YearsA pronounced slowdown in revenue growth versus earlier high-growth periods reduces margin-leverage runway and raises execution demands for new product ramps. Slower top-line expansion makes it harder to sustain rapid operating-margin gains and increases reliance on specific launches or geographies to restore higher growth.
Weak Free-cash-flow Conversion And Historical VolatilityFree cash flow equating to roughly one-third of net income indicates earnings are not fully converting to durable cash, limiting self-funded investment capacity. Combined with a history of volatile cash flow, this raises medium-term risk that operating profits may not consistently translate to reinvestable cash or shareholder returns.
Franchise And Geographic Headwinds (MIS Decline, Distributor Weakness)A sharp MIS ablation decline plus distributor and regional weakness create durable revenue concentration and execution risks. Deliberate throttling of onboarding preserves economics but constrains scale, meaning sustained recovery depends on resolving product-specific headwinds and improving distributor execution across markets.
MNTN FAQ
What was MNTN, Inc Class A’s price range in the past 12 months?
MNTN, Inc Class A lowest stock price was $7.67 and its highest was $32.00 in the past 12 months.
What is MNTN, Inc Class A’s market cap?
MNTN, Inc Class A’s market cap is $688.97M.
When is MNTN, Inc Class A’s upcoming earnings report date?
MNTN, Inc Class A’s upcoming earnings report date is Aug 04, 2026 which is in 6 days.
How were MNTN, Inc Class A’s earnings last quarter?
MNTN, Inc Class A released its earnings results on May 05, 2026. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.111 by -$0.001.
Is MNTN, Inc Class A overvalued?
According to Wall Street analysts MNTN, Inc Class A’s price is currently Undervalued.
Does MNTN, Inc Class A pay dividends?
MNTN, Inc Class A does not currently pay dividends.
What is MNTN, Inc Class A’s EPS estimate?
MNTN, Inc Class A’s EPS estimate is 0.19.
How many shares outstanding does MNTN, Inc Class A have?
MNTN, Inc Class A has 61,013,454 shares outstanding.
What happened to MNTN, Inc Class A’s price movement after its last earnings report?
MNTN, Inc Class A reported an EPS of $0.11 in its last earnings report, missing expectations of $0.111. Following the earnings report the stock price went down -22.799%.
Which hedge fund is a major shareholder of MNTN, Inc Class A?
Currently, no hedge funds are holding shares in MNTN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MNTN, Inc Class A Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.14 (134.77% Upside)
$20.14 (134.77% Upside)
Blogger Sentiment
Neutral
MNTN Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 158.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
51.37%
Trailing 12-Months
Company Description
MNTN, Inc Class A
MNTN, Inc. operates a technology platform that brings performance marketing to Connected TV. Its self-serve technology makes running TV ads as easy as search and social and helps brands to drive measurable conversions, revenue, site visits, and more. The company was formerly known as MNTN Digital, Inc. and changed its name to MNTN, Inc. in 2022. MNTN, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
MNTN Company Deck
MNTN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Overall the call conveyed solid top-line growth, expanding profitability, strong product adoption, and accelerated clinical trial progress — all meaningful positives. There are notable soft spots (a ~25% decline in MIS ablation, some international distributor weakness, modest sequential growth, and deliberate limits on SMB onboarding), but they appear manageable relative to the breadth of growth drivers and the company’s guidance for the year.View all MNTN earnings summariesMNTN Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$20.14
▲(134.77% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
11.41% Insiders
9.73% Mutual Funds
10.88% Other Institutional Investors
60.61% Public Companies and
Individual Investors









